An estimated 1.3 million people acquired HIV in 2023 - three times more than the 2025 global target. With a wide array of prevention choices, including the star of last month’s International AIDS Conference — a promising injectable that appears to offer six months of protection, providers are moving closer to being able to offer users, a variety of HIV prevention services. To ascertain demand, experts are calling for lower prices, faster regulatory approval, and engagement with communities.